Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1.2,4]triazolo[3.4-b][1.3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1.3,4-thiadiazol-3(2H)-yl moieties
A series of benzenesulfonamides incorporating aroylhydrazone, piperidinyl, sulfone, [1.2,4]triazolo[3.4-b][1.3,4]thiadiazinyl- or 2-(cyanophenyl-methylene)-1.3,4-thiadiazol-3(2H)-yl moieties was investigated as inhibitors of four α-carbonic anhydrases (CAs, EC 4.2.1.1), the human (h) isoforms hCA I, II (cytosolic, offtarget enzymes) and hCA IX and XII (transmembrane, tumor-associated isoforms). Low nanomolar activity was observed against hCA II (KIs of 0.56-17.1 nM) with these sulfonamides, whereas the slow cytosolic isoform hCA I was less inhibited by these compounds (KIs of 86.4 nM-32.8 µM). Most of these sulfonamides significantly inhibited CA IX, with KIs in the range of 4.5-47.0 nM, although some of the derivatives incorporating bulkier bicyclic moieties, as well as 2-thienyl fragments, showed a weaker activity against this isoform (KIs in the range 50.1-553 nM). All the investigated compounds also inhibited CA XII with KIs in the range 0.85-376 nM. The best inhibitors were those incorporating bulky [1.2,4]triazolo[3.4-b][1.3,4]thiadiazinyl moieties and 1.3,4-thiadiazol-3(2H)-yl groups.
